• CLSI DI03A

CLSI DI03A

Agglutination Analyses: Antibody Characteristics, Methodology, Limitations, and Clinical Validation; Approved Guideline, DI03-A

Clinical and Laboratory Standards Institute, 10/19/1993

Publisher: CLSI

File Format: PDF

$135.00$270.87


Published:19/10/1993

Pages:9

This guideline describes the specificity of antibodies and antigens for agglutination techniques; labeling information; and characteristics and limitations of agglutination methods.

This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the documents available for their informational content.

This document is available in electronic format only.

More CLSI standard pdf

CLSI M59-Ed1

CLSI M59-Ed1

Epidemiological Cutoff Values for Antifungal Susceptibility Testing, 1st Edition

$119.00 $238.51

CLSI POCT04-Ed3

CLSI POCT04-Ed3

Essential Tools for Implementation and Management of a Point-of-Care Testing Program, POCT04Ed3E

$90.00 $180.00

CLSI M57-Ed1 (R2022)

CLSI M57-Ed1 (R2022)

Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing

$90.00 $180.00

CLSI POCT17-Ed1

CLSI POCT17-Ed1

Use of Glucose Meters for Critically Ill Patients, 1st Edition, POCT17Ed1E

$106.00 $213.90